Elevated levels of GLB1, a lysosomal marker of cell senescence, is associated with increased liver fat, NAFLD, aging, and type 2 diabetes mellitus [98,99,100], and the low levels of GLB1 seen in our study is in contrast to our other markers pointing at accelerated aging. This evidence concerns the gene GLB1 and metabolic dysfunction-associated steatotic liver disease.